This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Ajay Soni: Innovator in Antibacterial Agents
Introduction
Ajay Soni is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His work focuses on innovative compounds that address critical health challenges.
Latest Patents
Ajay Soni holds a patent for "Tricyclic benzoxaboroles as antibacterial agents." This invention provides a tricyclic compound represented by a general formula that exhibits excellent antibacterial activity against Gram-negative bacteria, including those resistant to other treatments. The invention also emphasizes safety and includes production processes, pharmaceutical compositions, and uses of the compound as a pharmaceutical agent. The compounds are particularly useful for treating and preventing diseases such as complicated urinary tract infections, nosocomial pneumonia, intra-abdominal infections, and bacteremia. He has 1 patent to his name.
Career Highlights
Ajay Soni is currently employed at Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for serious bacterial infections.
Collaborations
He collaborates with talented professionals in his field, including Sangram Shesharao Deshmukh and Kedar Padmakar Purnapatre. Their combined expertise contributes to the advancement of research and development in antibacterial agents.
Conclusion
Ajay Soni's contributions to the field of antibacterial agents highlight his dedication to improving healthcare through innovation. His patent for tricyclic benzoxaboroles represents a significant advancement in the fight against resistant bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
